Global Export Authorizations Will Expand Protein Markets Despite Risks

Published
29 Nov 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
R$27.05
26.7% undervalued intrinsic discount
20 Aug
R$19.83
Loading
1Y
-22.9%
7D
5.1%

Author's Valuation

R$27.1

26.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 5.81%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 8.22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 7.98%

Shared on02 Apr 25
Fair value Increased 4.53%

AnalystConsensusTarget has decreased profit margin from 3.6% to 3.2% and increased future PE multiple from 25.5x to 29.0x.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 4.91%

AnalystConsensusTarget has increased profit margin from 3.1% to 3.7% and decreased future PE multiple from 31.4x to 25.4x.